Martingale Asset Management L P Organon & Co. Transaction History

Martingale Asset Management L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $1.21 Million - $1.48 Million	-51,728 Reduced 65.77%	26,918 $752,000
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $714,261 - $1.05 Million	30,524 Added 63.43%	78,646 $1.84 Million
Q2 2022 Aug 11, 2022	BUY	$31.66 - $38.9 $1.52 Million - $1.87 Million	48,122 New	48,122 $1.62 Million
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $505,863 - $629,723	-17,669 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $502,683 - $671,422	17,669 New	17,669 $534,000

810

201M

1.53M

1.07M

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.94B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.